End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
58.3 TWD | +3.37% | +5.23% | +15.90% |
Mar. 11 | TSH Biopharm Corporation Limited Announces Directorate Changes on April 1, 2024 | CI |
Mar. 11 | TSH Biopharm Corporation Limited Appoints Jung-Liang Kao as CFO on April 1, 2024 | CI |
Sales 2022 | 464M 14.52M | Sales 2023 | 811M 25.35M | Capitalization | 1.93B 60.38M |
---|---|---|---|---|---|
Net income 2022 | 61M 1.91M | Net income 2023 | 62M 1.94M | EV / Sales 2022 | 2.38 x |
Net cash position 2022 | 722M 22.58M | Net cash position 2023 | 765M 23.91M | EV / Sales 2023 | 1.44 x |
P/E ratio 2022 |
29.5
x | P/E ratio 2023 |
31.2
x | Employees | 76 |
Yield 2022 |
3.36% | Yield 2023 |
2.54% | Free-Float | 35.47% |
1 day | +3.37% | ||
1 week | +5.23% | ||
Current month | -8.33% | ||
1 month | -9.33% | ||
3 months | +15.67% | ||
6 months | +27.85% | ||
Current year | +15.90% |
Managers | Title | Age | Since |
---|---|---|---|
Ssu Yuan Yang
CEO | Chief Executive Officer | - | - |
Chen Ju Kan
DFI | Director of Finance/CFO | - | 10-08-31 |
Shu Ping Huang
ADM | Chief Administrative Officer | - | 10-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kang Chi Chou
BRD | Director/Board Member | - | - |
Chuan Lin
CHM | Chairman | 72 | - |
Hsin Yang Liu
PRN | Corporate Officer/Principal | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 58.3 | +3.37% | 259,882 |
24-03-26 | 56.4 | -2.08% | 263,374 |
24-03-25 | 57.6 | +3.78% | 110,044 |
24-03-22 | 55.5 | +0.91% | 53,640 |
24-03-21 | 55 | -0.72% | 74,468 |
End-of-day quote Taipei Exchange, March 26, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+15.90% | 69.93M | |
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+1.13% | 210B | |
+2.79% | 210B | |
-6.50% | 201B | |
-3.51% | 157B |